PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases-Reference-Cited by-同舟云学术

PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases

Published:2020-11-04 Issue:7 Volume:27 Page:1875-1881
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Kim Guowei^ORCID,Tan Hon Lyn,Sundar Raghav^ORCID,Lieske Bettina,Chee Cheng Ean^ORCID,Ho Jingshan,Shabbir Asim,Babak Maria V.,Ang Wee Han,Goh Boon Cher,Yong Wei Peng^ORCID,Wang Lingzhi^ORCID,So Jimmy B.Y.

Funder

MOH | National Medical Research Council

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial;Annals of Surgical Oncology;2024-09-13

2. PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial;European Journal of Surgical Oncology;2024-09

3. Top Peritoneal Surface Malignancy Articles from 2022 to Inform your Cancer Practice;Annals of Surgical Oncology;2024-05-03

4. The Crucial Value of Glutathione Peroxidase 2 to Understand the ‘Two-Faced’ Role of Reactive Oxygen Species in Lung Adenocarcinoma;Annals of Surgical Oncology;2024-05-03

5. Peritoneal Tumor DNA as a Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-Analysis;JCO Precision Oncology;2024-03